BackRocket Pharmaceuticals Overview

Rocket Pharmaceuticals Research & Development

Research & Development expenses for RCKT.

Quarterly R&D Expenses

$31.45M
↓ 12.49% YoY

As of Mar 31, 2026

Annual R&D Expenses (TTM)

$137.53M
↓ 14.26% YoY

Trailing 12 months ending Mar 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin